DABOGRATINIB
UNII FH245S2JZJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Dabogratinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FH245S2JZJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2800223-30-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FH245S2JZJ

CAS Registry Number

2800223-30-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DABOGRATINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H24Cl2N6O3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JOAFWIHZEBKYQK-OAHLLOKOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C190779

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

170647464

Unique identification number in the NCBI database of chemical substances.

INN ID

13462

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H](Oc1cc2c([nH]nc2-c3cnc(N4CC5(CN(C5)S(=O)(=O)C)C4)cc3)cc1)(c6c(Cl)cncc6Cl)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dabogratinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.